Nvidia, AbbVie, Vertex Pharmaceuticals And An Oil Giant: CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” Bryn Talkington of Requisite Capital Management named NVIDIA Corporation NVDA as her final trade.

NVIDIA recently announced a 10-for-1 stock split. The semiconductor giant revealed this decision during its recent quarterly earnings report. The split-adjusted trading commenced on Monday, June 10.

Jim Lebenthal of Cerity Partners picked Vertex Pharmaceuticals Incorporated VRTX, which is a biopharmaceutical company.

On Friday, Vertex revealed positive long-term data on CASGEVY™ (exagamglogene autotemcel) at the 2024 Annual European Hematology Association (EHA) Congress.

Don't forget to check out our premarket coverage here

Kevin Simpson of Capital Wealth Planning named ConocoPhillips COP, saying the acquisition of Marathon Oil Corporation MRO will be aggregate over time.

On Friday, BofA Securities analyst Kalei Akamine reinstated ConocoPhillips with a Buy rating and announced a price target of $147.

Rob Sechan of NewEdge Wealth said AbbVie Inc. ABBV has an attractive valuation, wonderful pipeline and a great yield.

On June 6, AbbVie released topline results from the Phase 2 PICCOLO trial evaluating investigational mirvetuximab soravtansine (Elahere) monotherapy in heavily pre-treated patients with folate receptor-alpha (FRα) positive, platinum-sensitive ovarian cancer (PSOC). The study met its primary endpoint with an objective response rate (ORR) of 51.9%.

Price Action:

• Nvidia shares gained 1.8% to close at $131.88 during Friday's session.
• Vertex Pharmaceuticals shares rose 0.4% to close at $480.73 on Friday.
• ConocoPhillips shares fell 1.4% to settle at $109.39 during Friday's session.
• AbbVie gained 1.2% to close at $168.59 on Friday.

Check This Out: Wall Street’s Most Accurate Analysts Weigh In On 3 Tech Stocks With Over 3% Dividend Yields

Image generated using artificial intelligence via Midjourney.